全部

1·The content of liver glycogen and the activity of liver glucokinase were studied.

实验结束后取肝脏测定糖原含量和葡萄糖激酶活性。

2·Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia.

【译】与葡萄糖激酶基因突变和延长患者的血管并发症的患病率，轻度高血糖。

3·The present invention discloses one new type of low toxicity glucokinase mutant and its preparation process and use.

本发明公开了一种新型低毒性葡激酶突变体，还公开了其制备方法及用 途。

4·Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus.

用于治疗糖尿病的、作为葡糖激酶激活剂的吡啶-2-基-氨基-1，2，4-噻二唑衍生物。

5·Objective To evaluate the role of glucokinase(GCK) gene in the pathogenesis of gestational diabetes mellitus(GDM) in Chinese.

目的探讨葡萄糖激酶（GCK）基因与妊娠糖尿病（GDM）易感性的关系。

6·Thus, it acts in a complementary mechanism to GKRP, which also regulates glucokinase protein expression and compartmentation .

这样，它对于GKRP的作用是一种补充机制， GKRP也调节葡萄糖激酶蛋白的表达和区间作用。

7·An experimental diabetes model was produced by intraperitoneal injection of alloxan. Blood glucose, liver glucokinase and liver glycogen contents were measured.

通过腹腔注射四氧嘧啶造小鼠糖尿病模型，观察血糖、肝糖原、葡萄糖激酶等指标。

8·Compared with the Saline control groups, the gene expression of glucokinase in the liver on model rats of the senna leaf laxation group remarkably decrease (P<0. 01).

肝脏中葡萄糖激酶基因表达情况：番泻叶泻下脾气虚组大鼠肝脏中葡萄糖激酶鑫因表达与生理盐水对照组比较显著降低（P<0 .01）。

葡糖激酶

1·Pyridin-2 -yl-amino-1, 2, 4 -thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus.

用于治疗糖尿病的、作为葡糖激酶激活剂的吡啶-2-基-氨基-1，2，4-噻二唑衍生物。

葡萄糖激酶

1·Thus, it acts in a complementary mechanism to GKRP, which also regulates glucokinase protein expression and compartmentation .

这样，它对于GKRP的作用是一种补充机制， GKRP也调节葡萄糖激酶蛋白的表达和区间作用。